Cargando…

Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation

Detalles Bibliográficos
Autores principales:	Mascarenhas, Kristen, Teh, Jennifer Berano, Peng, Kelly, Kim, Heeyoung, Sy, Andrew, Forman, Stephen J., Wong, F. Lennie, Nakamura, Ryotaro, Dadwal, Sanjeet S., Armenian, Saro H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391285/ https://www.ncbi.nlm.nih.gov/pubmed/31616064 http://dx.doi.org/10.1038/s41409-019-0717-8

Ejemplares similares

Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Chang, Ellen K., et al.
Publicado: (2021)

Late‐occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors
por: Sy, Andrew, et al.
Publicado: (2021)

Conditional Survival and Cause-specific Mortality after Autologous Hematopoietic Cell Transplantation for Hematological Malignancies
por: VanderWalde, Ari M., et al.
Publicado: (2012)

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Ali, Haris, et al.
Publicado: (2021)

Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation
por: Armenian, Saro H., et al.
Publicado: (2020)

Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial
por: Lee, Kyuwan, et al.
Publicado: (2023)

Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation
por: Slavin, Thomas P., et al.
Publicado: (2019)

The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
por: Ngo, Dat, et al.
Publicado: (2023)

Impact of Letermovir Use for Cytomegalovirus Prophylaxis on Re-Hospitalization Following Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of a Phase III Randomized Clinical Trial
por: Golan, Yoav, et al.
Publicado: (2021)

Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy
por: Nakamura, Ryotaro, et al.
Publicado: (2023)

Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant
por: Rhee, June-Wha, et al.
Publicado: (2023)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

Telehealth exercise to Improve Physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trial
por: Lee, Kyuwan, et al.
Publicado: (2022)

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes
por: Aldoss, Ibrahim, et al.
Publicado: (2021)

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation
por: Capoferri, Gioele, et al.
Publicado: (2023)

Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
por: Cabanillas Stanchi, Karin Melanie, et al.
Publicado: (2020)

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
por: Joshi, Maansi, et al.
Publicado: (2021)

Immunoglobulin and granulocyte-colony stimulating factor affecting infection and hematopoietic reconstruction in allogeneic hematopoietic stem cell transplantation
por: Ma, Le, et al.
Publicado: (2023)

The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation
por: Li, Ping, et al.
Publicado: (2023)

442 Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in Korean children under relatively short-term acyclovir prophylaxis
por: Han, Seung Beom, et al.
Publicado: (2014)

Cerebral toxoplasmosis after allogeneic hematopoietic stem cell transplantation diagnosed by megagenomic analysis
por: Shen, Kai, et al.
Publicado: (2019)

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Döring, Michaela, et al.
Publicado: (2012)

Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia
por: Zhang, Bing-Lei, et al.
Publicado: (2019)

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
por: Pophali, Prateek, et al.
Publicado: (2020)

A case of lupus miliaris disseminatus faciei after allogeneic hematopoietic stem cell transplantation
por: Zhang, Si, et al.
Publicado: (2019)

Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation
por: Meissner, Julia, et al.
Publicado: (2022)

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021)

First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up
por: Kuskonmaz, Baris, et al.
Publicado: (2022)

CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation
por: Calderin Sollet, Zuleika, et al.
Publicado: (2023)

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
por: Sora, Federica, et al.
Publicado: (2022)

The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis
por: Byun, Ja Min, et al.
Publicado: (2016)

Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation
por: Li, Po-Hsien, et al.
Publicado: (2021)

Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study
por: Han, Seung Beom, et al.
Publicado: (2017)

Herpes Zoster and Varicella
por: Chatterjee, Bijoy Krishna
Publicado: (1929)

Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC
por: Jondreville, Ludovic, et al.
Publicado: (2022)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
por: Pabon, Cindy M., et al.
Publicado: (2021)

Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia
por: Hassan, Mona Ali, et al.
Publicado: (2023)

Health Behaviors and Cancer Screening Practices in Long-term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)
por: Armenian, Saro H., et al.
Publicado: (2011)

1548. Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients
por: Baumrin, Emily, et al.
Publicado: (2018)

1760. Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Hematologic Malignancies and Hematopoietic Cell Transplant
por: Ross, Justine Abella, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u2f1h9haiailphdishpc9f31e8